Lactulose Clinical Trials
5 recruitingDrug
Phase 22Not Applicable2Phase 31Phase 41Phase 11
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy
Cancer
University of Chicago55 enrolled1 locationNCT07354100
Recruiting
Not Applicable
Effect of Single vs Repeated Cycles of a Combination of Granulocyte Colony Stimulating Factor and Darbepoetin vs Standard Medical Treatment on Immunometabolic Profile in Patient With Early Decompensated Cirrhosis.
Decompensated Liver Cirrhosis
Institute of Liver and Biliary Sciences, India60 enrolled1 locationNCT07002827
Recruiting
Not Applicable
Human Albumin Infusion in Liver Cirrhosis and Overt Hepatic Encephalopathy (HACHE)
Overt Hepatic Encephalopathy
General Hospital of Shenyang Military Region174 enrolled1 locationNCT06483737
Recruiting
Phase 4
BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HE
minimal hepatic encephalopathyHepatic EncephalopathyDecompensated Cirrhosis
Post Graduate Institute of Medical Education and Research, Chandigarh336 enrolled1 locationNCT06538077
Recruiting
Phase 2Phase 3
Efficacy and Safety of Clotrimazole+Lactulose Vaginal Suppositories Vs. Clotrimazole Monotherapy in Adult Women with Candidal Vaginitis/Vulvovaginitis
Candidal Vulvovaginitis (ICD-10 Code: B37.3)Vulvovaginal Candidiasis (VVC)
AVVA Pharmaceuticals Ltd.264 enrolled7 locationsNCT06835361